Delivery Order SPE2DR25D1106-SPE2DR26FJB4X
- Not listed
- The Defense Logistics Agency awarded a $5,061.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units). This is a non-set-aside competitive award with an ultimate completion date of December 9, 2025, with performance originating from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a relatively modest procurement action within the federal...
- The Defense Logistics Agency awarded a $1,154.95 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml) pharmaceutical product, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml units, with a ceiling value of $2,147.31. This competitively awarded, firm fixed-price delivery order is set to be completed by September 19, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive standing...
- The Defense Logistics Agency awarded a delivery order valued at $9,685.05 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml, 200 ml format) with a completion date of August 26, 2025. This firm fixed-price delivery order, awarded without set-aside provisions on August 25, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- AmerisourceBergen Drug Corp received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Ropivacaine 0.2% (200 mg/100 mL) in 100 mL units, with a ceiling value of $1,419.66 and a firm fixed price structure. The contract is scheduled for ultimate completion on September 25, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was issued with no set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ropivacaine 0.2% in 400 mg/200 mL vials with a ceiling value of $1,431.54. This is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and represents a non-competitive set-aside contract. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $4,400.42 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL), a local anesthetic pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,162.46 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml, 200 ml units) with a completion date of December 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL) in 200 mL units at a firm fixed price of $4,058.09. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The work is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL, 200 mL units) with a ceiling value of $5,149.90. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJB4XDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,810.25 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ropivacaine 0.2% in 400 mg/200 mL vials. This firm fixed price, non-set-aside contract is scheduled for completion by December 2, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, including the military and veteran healthcare networks. The company has demonstrated substantial capacity through numerous competitively awarded delivery orders covering a diverse portfolio of pharmaceutical products and medical supplies. This award reflects AmerisourceBergen's established role as a primary vendor within the DLA's pharmaceutical supply chain, enabling efficient procurement of essential medications and medical commodities to support Defense Health Agency operations and other federal healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 11/30/25 |